Straumann Holding Ag · SIX:STMN

Straumann — Q1 2019 Earnings Presentation

29 slides from Straumann's earnings presentation, 2019

1. Slide 1: First-quarter 2019

   First-quarter 2019 Webcast for investors, analysts & media

2. Slide 2: Disclaimer

   Disclaimer This presentation contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Straumann Group to differ m

3. Slide 3: Agenda

   Agenda First-quarter highlights Business and regional review Recent achievements & strategy in action Outlook 2019 Q&A and upcoming events

4. Slide 4: First-quarter highlights

   First-quarter highlights Marco Gadola, CEO

5. Slide 5: Good start to 2019 – further growth initiatives taken

   Good start to 2019 – further growth initiatives taken REVENUE GROWTH TOP PERFORMERS CHF 372m +17% organic 1 APAC & LATAM Up 15% on strong 2018 2.3%-point FX effect …sustain growth around 20%; performance Minor acquisition effect NAM & EMEA both post double- digit increases INNOVATION STREAM PORTFOLI

6. Slide 6: Strong growth continues – on track to deliver our full-year promises

   Strong growth continues – on track to deliver our full- year promises Organic revenue growth EMEA NAM FY 2018 14.6% FY 2018 20.0% Q1 2019 14.4% Q1 2019 17.4% APAC FY 2018 27.8% Q1 2019 22.1% LATAM FY 2018 20.2% Q1 2019 19.7% Group FY 2018 18.9% Q1 2019 17.1% 6

7. Slide 7: Business and regional review

   Business and regional review Peter Hackel, CFO

8. Slide 8: EMEA and NAM contribute two-thirds of organic growth

   EMEA and NAM contribute two-thirds of organic growth Revenue development (in CHF m, rounded) Regional share of 14.9% organic growth in CHF 17.1% organic 9% Latin 4.9 372.3 America 13.0 16.4 24% 20.2 Asia Pacific 324.1 -6.6 0.3 317.8 30% North Change in organic growth America 14.4% 17.4% 22.1% 19.7%

9. Slide 9: EMEA & North America outpacing the market

   EMEA & North America outpacing the market EMEA Revenue change (organic)  EMEA performance fuelled by countries in Eastern Europe and the 56% Middle East 19.3%  Key performers: Russia, Austria, and 17.0% 43% of Group 15.0% 14.4% Turkey; strong growth in Germany 11.9% 9.8%  Good growth across the b

10. Slide 10: Strong performance in Asia Pacific & Latin America

    Strong performance in Asia Pacific & Latin America APAC Revenue change (organic)  Impressive organic growth (+22%) 32.5% 33.1%56%  China maintains dynamism 22.1% 25.0% 22.1%  Japan progresses well 21.2%  Neodent rolled out in Australia, 19% of Group Indonesia and Thailand Q4 Q1 2018 Q2 Q3 Q4 Q1

11. Slide 11: Dynamic clear-aligner and biomaterials business

    Dynamic clear-aligner and biomaterials business Restorative & Implants Digital Biomaterials 11

12. Slide 12: Recent achievements & strategy in action

    Recent achievements & strategy in action Marco Gadola, CEO

13. Slide 13: Anthogyr – a high-quality European brand to further penetrate the non-premium segment

    Anthogyr – a high-quality European brand to further penetrate the attractive non-premium segment  Stake increased from 30% to full ownership  Consolidation 1 June 2019; integration started  Leading French implant manufacturer; established international provider of upper value implants  Comprehen

14. Slide 14: Further jewels in the crown

    Further jewels in the crown  Stake increased from 51% to 91%  Attractively-priced compatible prosthetics and implants  Participation increased from 50% to full ownership  Implants to address the lower value segment in Turkey, Middle East, N. Africa, and Eurasia  Consolidated as of 1 January 201

15. Slide 15: Esthetic dentistry solutions portfolio

    Esthetic dentistry solutions portfolio Multi-platform Implant systems Digital Orthodontic Biomaterials Preventive prosthetics brands Global Local brands brands & partners Technology 15

16. Slide 16: Innovation showcased at key events

    Innovation showcased at key events  Huge presence at AO, Chicago Midwinter, CIOSP & IDS  Key innovations launched; >100 new items presented  >50 lectures/live sessions at booths  Tens of thousands of views online  >3000 customer leads Watch the IDS video https://www.youtube.com/watch? v=GULQa2o

17. Slide 17: Meeting requirements for immediate solutions e.g. in edentulous treatments

    Meeting requirements for immediate solutions e.g. in edentulous treatments Removable solutions Fixed solutions new new new Straumann Straumann Straumann BLT and Straumann BLX Straumann Mini-Implantat Novaloc angulated abutments Pro Arch 17

18. Slide 18: An even broader range of digital options

    An even broader range of digital options Virtuo Vivo™ 3Shape TRIOS 4 Medit T-Series intraoral scanner DWOS 8 & CoDiagnostiX with Easy Modes; Carestream, Camfacture, Medit integrated 3D printing capsule system 18

19. Slide 19: Clear-aligner business launched in Brazil, China and Europe

    Clear-aligner business launched in Brazil, China and Europe ClearCorrect  Launched in Brazil and Europe  Production expansion  Fresh new branding Smyletec  Exclusive distribution agreement  Affordable, state-of-the-art solutions for China  World’s second largest market for clear aligners, expe

20. Slide 20: Group expands production in Brazil

    Group expands production in Brazil  Construction of new plant in Curitiba underway  11 000m2 production space created in first phase  Automated production of ClearCorrect clear aligners to serve LATAM market  Increased capacity for implant system components  Scheduled opening in Q4 2019 20

21. Slide 21: ClearCorrect and Align Technology settle patent disputes

    ClearCorrect and Align Technology settle patent disputes  Companies agree to drop patent disputes  Non-binding letter of intent to explore distribution & development of Align’s iTero® IO-scanner integrated in Straumann’s CARES® / DWOS® workflow  Straumann Group expects one-time expense of max CHF

22. Slide 22: Inspiring and engaging women in implant dentistry

    Inspiring and engaging women in implant dentistry  First WIN EMEA summit attended by 160 female dental professionals from 27 nations  #Power-up: Women@Straumann – internal program for female colleagues reflects external initiative  JUNTAS empowering women in Brazil; >200 female colleagues join pr

23. Slide 23: Outlook 2019

    Outlook 2019

24. Slide 24: Our 2019 guidance

    Our 2019 guidance Barring unforeseen circumstances Global implant market to continue to Market growth grow between 4-5% Our revenue Confident to outperform and achieve organic growth revenue growth in the low-teens percentage range Further improvement in the underlying1 Profitability EBITDA and EBIT

25. Slide 25: Estimated impact from adopting IFRS 16 (leases) in 2019

    Estimated impact from adopting IFRS 16 (leases) in 2019 Approx. IFRS 16 impact (in CHF million)1 Total Revenue Gross margin +0.5 EBITDA +18.0 EBIT +3.0 Financial results -5.0 Profit before tax -2.0 1 Barring unforeseen circumstances, major currency movements and/or change in business scope 25

26. Slide 26: Questions & answers

    Questions & answers straumanng'oup

27. Slide 27: Calendar of upcoming events

    Calendar of upcoming events 2019 Event Location 30 April First-quarter results Webcast 21 May UBS Healthcare conference New York 22 May Berenberg US conference Tarrytown (US) 04-05 June Vontobel Switzerland conference Interlaken (CH) 13 June Exane BNP Paribas CEO conference Paris 14 August First-hal

28. Slide 28: Straumann's currency exposure

    Straumann’s currency exposure Revenue breakdown FY20181 FX sensitivity CHF Average exchange rates (rounded) (+/- 10%) on full-year... 6% Other Closing 21% 2017 2018 2018 Revenue EBIT EUR 1 EURCHF 1.11 1.15 1.13 +/- 39m +/- 23m BRL 29% 8% 1 USDCHF 0.98 0.98 0.99 +/- 37m +/- 17m JPY 100 BRLCHF 30.69 2

29. Slide 29: Thank you

    straumanng'oup

Straumann Group — Q1 2019 Earnings Presentation on 6ix